Holen Sie sich die Stockscreener-App
145.61
0.39%
-1.0291
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GILD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Gilead Sciences Inc Aktie (GILD) Neueste Nachrichten
Gilead Sciences stock falls as investors reassess post-earnings rally - AD HOC NEWS
Gilead launches research facility in US for new medicine development - Yahoo Finance
NewEdge Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
How Bixlenvo Approval At Gilead Sciences (GILD) Has Changed Its Investment Story - simplywall.st
Gilead opens new building on existing Foster City campus - NBC Bay Area
Gilead National Ribbon Cutting Ceremony - Post Register
Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Assembly Bio stock gains after exercising Gilead profit option By Investing.com - Investing.com South Africa
Assembly Bio stock gains after exercising Gilead profit option - Investing.com India
Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program - The Manila Times
A $75 million Gilead payment is due in Q4, while Assembly Bio expects cash to fund operations into 2029. - Stock Titan
Gilead Opens 182,000-Square-Foot Research Center in Foster City - Contract Pharma
Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement - tradingkey.com
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines - Gilead Sciences
Gilead Sciences stock gains on fresh analyst buy rating and Q2 loss swing - AD HOC NEWS
Gilead Sciences Slides 3.4% as Investors Digest Prior Gains and Ongoing Pricing Risks - Moomoo
Gilead opens research center as $32 billion US build-out continues - The Pharma Letter
Gilead Sciences, Inc. $GILD Shares Purchased by Groupe la Francaise - MarketBeat
California State Teachers Retirement System Has $30.47 Billion Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market? - Yahoo Finance
[Press release] FDA approves Gilead’s Bixlenvo™, a new once-daily single tablet option for virologically suppressed adults with HIV, including those on complex regimens - European AIDS Treatment Group
Gilead Sciences stock gains after narrowing Q2 loss and firming 2026 guidance - AD HOC NEWS
Unlocking Opportunity: Dominate the Market of CAR/TCR/TIL Therapies in Oncology with Confidence. See Exactly How Gilead, Cellectis, MediGene, GenScript, and CARsgen Are Positioned to Win Through 870+ Rivals - GlobeNewswire Inc.
Gilead Sciences, Inc. $GILD Holdings Raised by HighTower Advisors LLC - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $130.42 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating the Prospects with a 4.25% Potential Upside - DirectorsTalk Interviews
Could Gilead Sciences (NASDAQ:GILD) Remain a Nasdaq Focus? - Kalkine Media
Amundi Has $1.23 Billion Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Saudi Central Bank Acquires 41,091 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Strategically Prepares for HIV Market Changes - Intellectia AI
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play? - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Will New HIV and Oncology Approvals Redefine Gilead Sciences' (GILD) Treatment Platform Narrative? - Yahoo Finance
Gilead Keeps Writing Bigger Checks—But Can the Drugs Keep Paying for Them? - AOL.com
Q&A: Gilead's Betty Chiang on what Bixlenvo means for HIV patients on complex regimens - The Pharma Letter
Gilead Sciences (NASDAQ:GILD): A Quality Dividend Stock for Income Investors - ChartMill
NEOS Investment Management LLC Has $120.08 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
TD Waterhouse Canada Inc. Sells 70,572 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
AXQ Capital LP Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Gilead Sciences (GILD) Chairman & CEO Daniel O'Day Sells 15,000 Shares - GuruFocus
Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report? - Yahoo Finance
Gilead Sciences Q1 EPS Estimate Raised by Zacks Research - MarketBeat
Is Gilead Sciences Stock Outperforming the S&P 500? - Yahoo Finance
Nykredit A S Makes New $177.13 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
iSAM Funds UK Ltd Buys New Stake in Gilead Sciences, Inc. $GILD - MarketBeat
B. Metzler seel. Sohn & Co. AG Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock - MarketBeat
Gilead (NASDAQ: GILD) CEO sells 15,000 shares near $150 - Stock Titan
Gilead Sciences stock gains as analysts turn more positive - AD HOC NEWS
Gilead Sciences (NASDAQ:GILD) Raised to "Strong-Buy" at Zacks Research - MarketBeat
Zacks Research Lifts Earnings Estimates for Gilead Sciences - MarketBeat
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Can Bixlenvo Unlock New Growth for Gilead's HIV Business? - Yahoo Finance
Gilead Sciences stock holds near $146 after a revenue beat - AD HOC NEWS
Gilead Sciences (NASDAQ:GILD) Beats Revenue Views Despite Loss - Kalkine Media
Gilead (GILD) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Wall Street Analysts See Gilead (GILD) as a Buy: Should You Invest? - Yahoo Finance
Erste Group Bank Comments on Gilead Sciences FY2026 Earnings - MarketBeat
Railway Pension Investments Ltd Sells 7,769 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Ancora Advisors LLC Sells 9,072 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
FDA Approves Gilead's New Single Tablet HIV Regimen - Benzinga
Gilead Sciences, Inc. $GILD Shares Sold by Quantitative Investment Management LLC - MarketBeat
Headlands Technologies LLC Buys Shares of 49,478 Gilead Sciences, Inc. $GILD - MarketBeat
Hennessy Advisors Inc. Raises Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Van ECK Associates Corp Sells 488,138 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Flputnam Investment Management Co. Sells 67,582 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Wellington Management Group LLP Sells 838,308 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Nissay Asset Management Corp Japan Boosts Position in Gilead Sciences, Inc. $GILD - MarketBeat
Braun Stacey Associates Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Archer Investment Corp Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Beacon Pointe Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
0.03%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):